Cocrystal Pharma (COCP) Earnings Date & Reports

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses... Show more

Industry: #Pharmaceuticals Generic

Get AI intraday signals

A.I. Advisor

published Earnings

COCP is expected to report earnings to fall 34.78% to -15 cents per share on November 16

Cocrystal Pharma COCP Stock Earnings Reports

Q3'26

Est.

$-0.15

Q2'26

Missed

by $0.06

Q1'26

Beat

by $0.09

Q4'25

Beat

by $0.12

Q3'25

Beat

by $0.15

The last earnings report on August 31 showed earnings per share of -23 cents, missing the estimate of -16 cents. With 40.53K shares outstanding, the current market capitalization sits at 23.69M.

View a ticker or compare two or three

COCP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for COCP